Cargando…

Parkinson’s disease laterality: a (11)C-PE2I PET imaging study

Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roussakis, Andreas-Antonios, Zeng, Zhou, Lao-Kaim, Nicholas P., Martin-Bastida, Antonio, Piccini, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880931/ https://www.ncbi.nlm.nih.gov/pubmed/32880071 http://dx.doi.org/10.1007/s00415-020-10204-y

Ejemplares similares

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019)

Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with (11)C-BU99008 PET
por: Mohamed, Mohamed A, et al.
Publicado: (2022)

Dopamine Transporter Density in de novo Parkinson’s Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2019)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

Dissociable effects of age and Parkinson’s disease on instruction-based learning
por: Parkin, Beth L, et al.
Publicado: (2021)

Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease
por: Li, Weihua, et al.
Publicado: (2020)

Sertraline treatment influences [(18)F]FE-PE2I PET imaging for Parkinsonism
por: Justesen, Thomas E. H., et al.
Publicado: (2023)

Restorative Strategies in Movement Disorders: the Contribution of Imaging
por: Lao-Kaim, Nicholas P., et al.
Publicado: (2017)

A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2023)

Reliability of dopamine transporter PET measurements with [(18)F]FE-PE2I in patients with Parkinson’s disease
por: Kerstens, Vera S., et al.
Publicado: (2020)

[(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2022)

Patterns of grey matter loss associated with motor subscores in early Parkinson's disease
por: Li, Xingfeng, et al.
Publicado: (2017)

Longitudinal DAT changes measured with [(18)F]FE-PE2I PET in patients with Parkinson’s disease; a validation study
por: Kerstens, V.S., et al.
Publicado: (2023)

PE and PET oligomers’ interplay with membrane bilayers
por: Järvenpää, Joni, et al.
Publicado: (2022)

Correction: [(18)F]FE-PE2I PET is a feasible alternative to [(123)I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
por: Marner, Lisbeth, et al.
Publicado: (2023)

Accuracy and precision of zero-echo-time, single- and multi-atlas attenuation correction for dynamic [(11)C]PE2I PET-MR brain imaging
por: Sousa, João M., et al.
Publicado: (2020)

[(18)F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
por: Kerstens, Vera S., et al.
Publicado: (2023)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

PE11, a PE/PPE family protein of Mycobacterium tuberculosis is involved in cell wall remodeling and virulence
por: Singh, Parul, et al.
Publicado: (2016)

Genome-Wide Identification of SPX Family Genes and Functional Characterization of PeSPX6 and PeSPX-MFS2 in Response to Low Phosphorus in Phyllostachys edulis
por: Luo, Jiali, et al.
Publicado: (2023)

(11)C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α‐Synuclein Fibrils in vitro and Crosses the Blood‐Brain Barrier
por: Maurer, Andreas, et al.
Publicado: (2020)

Pulmonary valve papillary fibroelastoma: to PE or not to PE
por: Kirk, Frazer, et al.
Publicado: (2023)

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease
por: Rolinski, Michal, et al.
Publicado: (2016)

Overexpression of PeHKT1;1 Improves Salt Tolerance in Populus
por: Xu, Meng, et al.
Publicado: (2018)

Simplified quantification of [(18)F]FE-PE2I PET in Parkinson’s disease: Discriminative power, test–retest reliability and longitudinal validity during early peak and late pseudo-equilibrium
por: Brumberg, Joachim, et al.
Publicado: (2020)

Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson’s disease)
por: Schwarz, Stefan T, et al.
Publicado: (2017)

Personnel (PE)
Publicado: (1964)

Personnel (PE)
Publicado: (1965)

Personnel (PE)
Publicado: (1964)

Personnel (PE)
Publicado: (1965)

Lateralization in (11)C‐Metomidate PET and outcome of adrenalectomy in primary aldosteronism
por: Isojärvi, Juhani, et al.
Publicado: (2022)

(11)C‐PK11195 PET imaging and white matter changes in Parkinson’s disease dementia
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE
por: Das, Jeeban P., et al.
Publicado: (2020)

Structural Analysis using SHALiPE to Reveal RNA G‐Quadruplex Formation in Human Precursor MicroRNA
por: Kwok, Chun Kit, et al.
Publicado: (2016)

Validation of dynamic [(18)F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [(15)O]H(2)O PET
por: Jakobson Mo, Susanna, et al.
Publicado: (2022)

Human biodistribution and dosimetry of [(11)C]-UCB-J, a PET radiotracer for imaging synaptic density
por: Cawthorne, Christopher, et al.
Publicado: (2021)

Superiority of [(11)C]methionine over [(18)F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer
por: Kubota, Yutaro, et al.
Publicado: (2023)

Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [(18)F]FE-PE2I-OH for Translational Dopamine Transporter Imaging
por: Schou, Magnus, et al.
Publicado: (2023)

Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer
por: Elkholi, Islam E., et al.
Publicado: (2021)

Neuroinflammation in frontotemporal lobar degeneration revealed by (11)C‐PBR28 PET
por: Kim, Min-Jeong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0k07lecajp21md7gidvl3e55li